4.6 Article

Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Exploring the Selectivity Profile of Sigma Receptor Ligands by Molecular Docking and Pharmacophore Analyses

Giada Righetti et al.

Summary: The exploration of structure-activity relationship of aR ligands through computational methods provides useful guidelines for the rational design of more selective compounds.

MEDICINAL CHEMISTRY (2021)

Review Infectious Diseases

Current State of Respiratory Syncytial Virus Disease and Management

Archana Chatterjee et al.

Summary: Respiratory syncytial virus (RSV) is a significant cause of hospitalizations due to pneumonia and bronchiolitis. Palivizumab is currently the only immunoprophylaxis available for specific high-risk pediatric populations, but vaccine development for RSV has been unsuccessful.

INFECTIOUS DISEASES AND THERAPY (2021)

Review Infectious Diseases

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

Joseph B. Domachowske et al.

Summary: RSV is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults, with current treatment primarily supportive. Palivizumab is the only licensed immunoprophylaxis for RSV disease in specific high-risk pediatric populations, but challenges such as cost and changing policy exist. New antiviral treatments for RSV are in early development stages, with promising long-acting monoclonal antibodies showing potential in early clinical trials.

INFECTIOUS DISEASES AND THERAPY (2021)

Article Chemistry, Medicinal

Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion

G. Stuart Cockerill et al.

Summary: RV521, an orally bioavailable inhibitor of RSV fusion, demonstrated potent antiviral efficacy against various RSV strains and clinical isolates with efficient penetration into lung tissue. In human volunteers experimentally infected with RSV, RV521 showed a significant reduction in viral load and symptoms, highlighting its promising antiviral effects.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus

Nicole Pribut et al.

ACS INFECTIOUS DISEASES (2020)

Article Chemistry, Medicinal

JNJ-5371678, Defining a Role for Fusion Inhibitors in the Treatment of Respiratory Syncytial Virus

G. Stuart Cockerill

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules

Antoine Daina et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Chemistry, Medicinal

State of the Art in Respiratory Syncytial Virus Drug Discovery and Development

G. Stuart Cockerill et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors

Song Feng et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Multidisciplinary Sciences

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Dirk Roymans et al.

NATURE COMMUNICATIONS (2017)

Review Respiratory System

Respiratory syncytial virus: prospects for new and emerging therapeutics

Patricia A. Jorquera et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)

Article Pharmacology & Pharmacy

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery

Elisabeth Heylen et al.

BIOCHEMICAL PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Molecular mechanism of respiratory syncytial virus fusion inhibitors

Michael B. Battles et al.

NATURE CHEMICAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

PLIP: fully automated protein-ligand interaction profiler

Sebastian Salentin et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Pharmacology & Pharmacy

Beware of docking!

Yu-Chian Chen

TRENDS IN PHARMACOLOGICAL SCIENCES (2015)

Article Biochemistry & Molecular Biology

Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents

Michele Tonelli et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Biology

Docking assay of small molecule antivirals to p7 of HCV

Leon Bichmann et al.

COMPUTATIONAL BIOLOGY AND CHEMISTRY (2014)

Article Chemistry, Medicinal

Predictive in silico off- target profiling in drug discovery

Friedemann Schmidt et al.

FUTURE MEDICINAL CHEMISTRY (2014)

Article Biochemical Research Methods

Shaping the interaction landscape of bioactive molecules

David Gfeller et al.

BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function

Nadine Schneider et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)

Article Biochemistry & Molecular Biology

Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives

Michele Tonelli et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Computer Science, Software Engineering

Molecular surfaces on proteins via beta shapes

Joonghyun Ryu et al.

COMPUTER-AIDED DESIGN (2007)

Article Multidisciplinary Sciences

Targeting a binding pocket within the trimer-of-hairpins: Small-molecule inhibition of viral fusion

C Cianci et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Chemistry, Medicinal

Molecular properties that influence the oral bioavailability of drug candidates

DF Veber et al.

JOURNAL OF MEDICINAL CHEMISTRY (2002)

Article Biochemical Research Methods

The Protein Data Bank

HM Berman et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)

Article Chemistry, Physical

Symplectic algorithm for constant-pressure molecular dynamics using a Nose-Poincare thermostat

JB Sturgeon et al.

JOURNAL OF CHEMICAL PHYSICS (2000)